Destiny Wealth Partners LLC purchased a new stake in shares of RTX Corporation (NYSE:RTX - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,406 shares of the company's stock, valued at approximately $497,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. MorganRosel Wealth Management LLC purchased a new position in RTX in the first quarter worth $26,000. Summit Securities Group LLC acquired a new stake in shares of RTX in the 1st quarter worth $40,000. McClarren Financial Advisors Inc. purchased a new position in RTX during the 1st quarter worth $44,000. Migdal Insurance & Financial Holdings Ltd. acquired a new position in RTX during the 1st quarter valued at about $50,000. Finally, Financial Gravity Asset Management Inc. purchased a new stake in RTX in the first quarter valued at about $50,000. Hedge funds and other institutional investors own 86.50% of the company's stock.
RTX Stock Down 0.6%
NYSE:RTX opened at $160.45 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.01 and a quick ratio of 0.75. The company's fifty day moving average price is $156.70 and its 200-day moving average price is $142.40. RTX Corporation has a 1-year low of $112.27 and a 1-year high of $163.03. The firm has a market capitalization of $214.77 billion, a P/E ratio of 35.26, a PEG ratio of 2.97 and a beta of 0.67.
RTX (NYSE:RTX - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The company reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.45 by $0.11. RTX had a net margin of 7.35% and a return on equity of 12.89%. The company had revenue of $21.58 billion during the quarter, compared to the consensus estimate of $20.68 billion. During the same period in the previous year, the firm posted $1.41 earnings per share. The firm's quarterly revenue was up 9.4% on a year-over-year basis. RTX has set its FY 2025 guidance at 5.800-5.950 EPS. As a group, equities research analysts anticipate that RTX Corporation will post 6.11 EPS for the current year.
Insider Transactions at RTX
In other RTX news, insider Troy D. Brunk sold 7,654 shares of the business's stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $155.20, for a total value of $1,187,900.80. Following the completion of the transaction, the insider directly owned 16,442 shares of the company's stock, valued at approximately $2,551,798.40. The trade was a 31.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Shane G. Eddy sold 25,968 shares of the firm's stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $159.79, for a total transaction of $4,149,426.72. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 56,635 shares of company stock valued at $8,947,010. 0.15% of the stock is owned by insiders.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on RTX shares. Citigroup boosted their price target on RTX from $148.00 to $182.00 and gave the stock a "buy" rating in a research note on Monday, July 14th. Barclays lifted their target price on shares of RTX from $130.00 to $153.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 29th. Morgan Stanley upped their price target on shares of RTX from $165.00 to $180.00 and gave the company an "overweight" rating in a research note on Wednesday, July 23rd. UBS Group lifted their price objective on shares of RTX from $166.00 to $177.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. Finally, The Goldman Sachs Group upped their target price on RTX from $114.00 to $126.00 and gave the company a "neutral" rating in a research report on Monday, June 23rd. Three investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $158.87.
Read Our Latest Research Report on RTX
About RTX
(
Free Report)
RTX Corporation, an aerospace and defense company, provides systems and services for the commercial, military, and government customers in the United States and internationally. It operates through three segments: Collins Aerospace, Pratt & Whitney, and Raytheon. The Collins Aerospace Systems segment offers aerospace and defense products, and aftermarket service solutions for civil and military aircraft manufacturers and commercial airlines, as well as regional, business, and general aviation, defense, and commercial space operations.
Featured Stories
Want to see what other hedge funds are holding RTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RTX Corporation (NYSE:RTX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider RTX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RTX wasn't on the list.
While RTX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.